Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 22, 2025 09:00 ET | Source: Targeted Bioscience

Targeted Bioscience Unveils Revolutionary Extracellular Vesicle Isolation Kit

Jupiter, FL, Jan. 22, 2025 (GLOBE NEWSWIRE) -- Targeted Bioscience, a leader in cutting-edge biotechnology solutions, is proud to announce the launch of its groundbreaking Extracellular Vesicle (EV)...
April 26, 2023 07:30 ET | Source: Evelo Biosciences, Inc.

Evelo Biosciences Provides Clinical Updates

– Topline Data from fourth cohort of EDP1815 Phase 2 trial in atopic dermatitis did not meet primary endpoint –– Company will focus on development of extracellular vesicles (EVs) –– First EV...
March 16, 2023 07:00 ET | Source: Evelo Biosciences, Inc.

Evelo Biosciences Announces Fourth Quarter and Full Year 2022 Financial Results and Business Highlights

CAMBRIDGE, Mass., March 16, 2023 (GLOBE NEWSWIRE) -- Evelo Biosciences, Inc. (Nasdaq: EVLO), (“Evelo” or the “Company”) a clinical stage biotechnology company developing a novel platform of orally...
February 27, 2023 06:00 ET | Source: Evelo Biosciences, Inc.

Evelo Biosciences Reports that EDP2939, its First Oral Extracellular Vesicle Product Candidate, Commenced Dosing in a Phase 2 Psoriasis Trial

– Completed first blinded, placebo-controlled cohort in human volunteers with no safety or tolerability concerns – – Dosing in EDP2939 Phase 2 trial in patients with moderate psoriasis has been...